•  verdict

Benicar (olmesartan medoxomil) is an angiotensin II receptor antagonist. It is used to treat high blood pressure in adults and children 6 years and above. By preventing the blood vessels from narrowing, the blood pressure is lowered and blood flow is improved. It may be used alone or in combination with other antihypertensive agents, such as Benicar HCT (olmesartan with hydrochlorothiazide, a diuretic), Azor (olmesartan with amlodipine, a calcium channel blocker), and Tribenzor (olmesartan with hydrochlorothiazide and amlodipine).

Serious Alleged Injuries may include:

  • Sprue-like enteropathy
  • Joint or Pain Muscle
  • Stomach Pain, Nausea, Vomiting
  • Weakness
  • Dizziness

FDA Safety Warnings:

On July 03, 2013, the U.S Food and Drug Administration (FDA) issued a warning to the manufacturer of Benicar. The warning stated that the side effects of this drug were not disclosed to the patients, as well as prescribers that this drug can cause intestinal problems known as sprue-like enteropathy (severe, chronic diarrhea with substantial weight loss). As result of its evaluation, the FDA announced that olmesartan drugs would update their label to include the risk of sprue-like enteropathy.

Benicar also has a black-box warning regarding the risk of birth defects in women who are pregnant while taking the medication

Legal Updates:

TThe company eventually settled with the U.S. Department of Justice on an amount of $39 million. The company had been charged under the False Claims Act.

Many lawsuits were filed against the company by individuals and state attorneys

Daiichi Sankyo and Forest Laboratories faced about 2,000 Benicar lawsuits as a result of gastrointestinal illnesses. In August 2017, the manufacturers agreed to pay $300 million to settle the product liability claims by those who suffered chronic diarrhea and other gastrointestinal injuries after using Benicar, Azor, and Tribenzor.


  • Usage of Benicar in Pharmacy Records
  • Duration of Usage
  • Proof of Injury in Medical Records.

Medical Record Review and claim validation of Benicar case should take approximately 3 hours in most instances; however, this approximation may vary in cases based on the volume of records.

We are social:



NSIC-CRISIL has assigned a "SE 2A" rating to Neural IT, indicating a company with High Performanc...

ISO 27001 Certification

Neural IT is officially ISO 27001:2013 (ISO 27001) certified by Alcumus ISOQAR Limited as the Cer...


Neural IT has successfully implemented HIPAA for securing Health records....



NYSTLA - "Neural IT is proud to be associated with NYSTLA (New York State Trial Lawyers Associati...


CAOC - "Neural IT is proud to be associated with CAOC (Consumer Attorneys of California) as a Ven...


CAALA - "Neural IT is proud to be associated with CAALA (Consumer Attorneys Association of Los An...

News & Events

Friends Of CAALA 2020
It is a treasured moment for Neural IT to be associated as an Affiliate Member for so many years and receive an…
Amidst the chaos of COVID-19 pandemic, we have something to cheer about as today is National Smile Day, and a smile is…
Happy Mother's Day from Neural IT
The cagey pandemic has halted our lives, but the only spirits that kept igniting during the crisis are the ones whom we…

Latest Tweets